These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18565870)

  • 1. Vasopressin in septic shock.
    Boyle WA; Leone M
    N Engl J Med; 2008 Jun; 358(25):2736; author reply 2737-8. PubMed ID: 18565870
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasopressin in septic shock.
    Dünser MW; Hasibeder WR; Wenzel V
    N Engl J Med; 2008 Jun; 358(25):2736; author reply 2737-8. PubMed ID: 18572442
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasopressin in septic shock.
    Landry DW; Oliver JA
    N Engl J Med; 2008 Jun; 358(25):2736-7; author reply 2737-8. PubMed ID: 18572443
    [No Abstract]   [Full Text] [Related]  

  • 4. Septic shock--vasopressin, norepinephrine, and urgency.
    Parrillo JE
    N Engl J Med; 2008 Feb; 358(9):954-6. PubMed ID: 18305271
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anesthetic management using vasopressin for a patient complicated with septic shock].
    Matsuno Y; Saito K; Hirabayashi Y; Seo N
    Masui; 2006 Nov; 55(11):1398-400. PubMed ID: 17131893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin in septic shock.
    Mogyorosi A
    N Engl J Med; 2008 Jun; 358(25):2737; author reply 2737-8. PubMed ID: 18572444
    [No Abstract]   [Full Text] [Related]  

  • 7. Low dose vasopressin for septic shock: where does it belong in therapy?
    Johnson TJ
    S D J Med; 2004 Jul; 57(7):255-6. PubMed ID: 15332318
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Flannery AH
    J Intensive Care Med; 2019 Jan; 34(1):79-80. PubMed ID: 30798672
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose vasopressin infusion can be an alternative in treating patients with refractory septic shock combined with chronic pulmonary hypertension--a case report.
    Wang HJ; Wong CS; Chiang CY; Yeh CC; Cherng CH; Ho ST; Wu CT
    Acta Anaesthesiol Sin; 2003 Jun; 41(2):77-80. PubMed ID: 12934421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
    Saad AF; Maybauer MO
    J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin in septic shock: clinical equipoise mandates a time for restraint.
    Russell JA
    Crit Care Med; 2003 Nov; 31(11):2707-9. PubMed ID: 14605551
    [No Abstract]   [Full Text] [Related]  

  • 13. Intractable hypotension in septic shock: successful treatment with vasopressin in an infant.
    Leibovitch L; Efrati O; Vardi A; Matok I; Barzilay Z; Paret G
    Isr Med Assoc J; 2003 Aug; 5(8):596-8. PubMed ID: 12929303
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
    Lupei MI; Beilman GJ; Chipman JG; Mann HJ
    Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fontan operation, vasopressin and septic shock: a case report on the usual treatment in a peculiar setting.
    Vitale V; Ricci Z; Favia I; Fragasso T; Cogo P; Rossi E
    Pediatr Cardiol; 2011 Dec; 32(8):1273-4. PubMed ID: 21938541
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasopressin: A tool as rescue therapy? Take care of dosages and adverse effects!
    Angstwurm M
    Crit Care Med; 2005 Nov; 33(11):2713-4. PubMed ID: 16276218
    [No Abstract]   [Full Text] [Related]  

  • 18. The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy.
    Sawa N; Ubara Y; Katori H; Hoshino J; Suwabe T; Takemoto F; Uchida N; Masuoka K; Wake A; Taniguchi S; Takaichi K
    Clin Nephrol; 2009 Aug; 72(2):129-36. PubMed ID: 19640370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine.
    Nguyen HB; Lu S; Possagnoli I; Stokes P
    J Intensive Care Med; 2017 Aug; 32(7):451-459. PubMed ID: 27189952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral administration of vasopressin for catecholamine-resistant hypotension complicated by skin necrosis.
    Bunker N; Higgins D
    Crit Care Med; 2006 Mar; 34(3):935; author reply 935-6. PubMed ID: 16505698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.